Aims
Introduction
Ca 2+ waves are thought to be important in the aetiology of a number of different forms of ventricular tachyarrhythmia, particularly in heart failure (HF) and catecholaminergic polymorphic ventricular tachycardia (CPVT). 1 The mechanisms for these arrhythmias are thought to be associated with elevated levels of spontaneous sarcoplasmic reticulum (SR) Ca 2+ release for a given SR load. 1, 2 In other words, the threshold SR Ca 2+ content for store-overload-induced Ca 2+ release is reduced in both CPVT and in HF, 2 -4 leading to Ca 2+ spark and wave generation. In CPVT, this is related to mutations of the cardiac ryanodine receptor (RyR2) or absence of calsequestrin, whereas in HF this may relate to post-translational modification of the RyR2, such as hyperphosphorylation. 2, 5 There has been recent interest in pharmacological agents which target potentially arrhythmogenic Ca 2+ waves. Flecainide, a drug that has been used for many years clinically for its sodium current (I Na )-reducing properties, has shown efficacy in the treatment of CPVT patients. 6, 7 However, the mechanism of action producing this clinical effect is debated. In a mouse model of CPVT, Knollmann and colleagues 7 -9 have shown that flecainide reduces Ca 2+ wave frequency in both intact and permeabilized myocytes and have provided evidence that this is related to a direct action on the RyR2 via an open-state block of the channel. In contrast, similar experiments in both intact and permeabilized myocytes have been repeated by Liu et al. 10 (although in a different mouse model of CPVT), and no effect on Ca 2+ wave frequency was found despite similar experimental conditions. The conclusion of Liu et al. was that the reduction in I Na caused by flecainide affected the threshold potential, which decreased the number of spontaneous action potentials triggered by delayed after-depolarizations (DADs) associated with Ca 2+ waves.
Our aim in this study was to assess whether flecainide had an effect on Ca 2+ sparks and waves and to further investigate the mechanism.
We observed SR Ca 2+ release events in intact rat ventricular cardiomyocytes from healthy rats. We show via a variety of pharmacological and electrophysiological interventions that a reduction in I Na during cellular contraction can reduce the frequency of Ca 2+ sparks and waves in the diastolic period. We also show that, in the case of flecainide, the I Na blocking effects are more relevant to wave reduction under our experimental conditions than RyR2 stabilization. Finally, we explore the mechanism of this wave reduction. We conclude that the most likely explanation for the reduction in the presence of I Na blockade is that it prevents an increase in [ Figure S1A ). This preliminary series of experiments established that 30 s of 5 Hz stimulation (after 2 min of stable contraction at 0.5 Hz) would consistently produce Ca 2+ waves in normal tyrode (NT) in the quiescent interval.
Voltage clamp technique
Cells were voltage-clamped using an amphotericin-perforated patch technique. The switch clamp technique [with an Axoclamp 2B amplifier (Axon Instruments)] was used to overcome any changes in access resistance that may have occurred over the course of an experiment. Myocytes were clamped at 280 or 240 mV and depolarized to 0 mV for 100 ms to cause contraction with and without I Na activation, respectively. A 5 Hz stimulation train was followed by a quiescent period during which the membrane potential was held at 280 mV for 30 s, and wave frequency was assessed as before.
Data-pairing and statistical analysis
Where possible, data were obtained in a paired fashion and drugs applied or washed off in the form of a cross-over protocol alternating from cell to cell ( Figure 1A ). For example, the first cell had the drug applied following a control period, whereas the next cell had drug applied first with subsequent wash-off. As a result, paired t-tests were used for significance testing unless stated. Depending on the data, Student's t-tests, log-rank, and repeatedmeasures analysis of variance (ANOVA) were also used to assess effects. Results were considered statistically significant if the P-value was ,0.05. Unless otherwise indicated, results are expressed as mean + standard error of the mean.
Results
3.1 Flecainide has no effect on the Ca Figure S1B and C). SR load was measured using a 20 mM caffeine spritz in 0Na + /0Ca 2+ solution following field stimulation at 5 Hz to mimic conditions used to assess waves ( Figure 1C ) and was unchanged by flecainide. Figure 1D and E). Spark morphology was unchanged (see Supplementary material online, Figure S2A -D).
Flecainide reduces
We predicted that the reduction in spontaneous Ca 2+ sparks from the SR in the presence of flecainide would result in a reduction in wave frequency. In order to test this hypothesis, 5 Hz stimulation was used to produce waves. There was a reduction in Ca 2+ wave frequency in the presence of flecainide ( Figure 2A ) from 0.23 + 0.04 to 0.10 + 0.02 waves/s (P ¼ 0.001). Since it has previously been suggested that a prolonged period of flecainide loading is required to produce SR Ca 2+ release reduction, 9 we tested whether prolonged exposure would have any additional effect. Thirty minutes of exposure produced no further wave reduction compared to 5 mins (see Supplementary material online, Figure S3A ). The time from the last transient to the first wave, defined as the 'wave-free survival period' for each cell, and represented in KaplanMeier survival curve format in Figure 2B , was also significantly increased in the presence of flecainide. In addition, wave velocity was reduced ( Figure 2C ) from 146.4 + 4.7 to 130 + 5.8 mm/s (P ¼ 0.04 by Student's t-test), suggesting that wave propagation is also altered by flecainide. Confocal line-scanning reveals both the reduction in Ca 2+ waves and how this is related to a reduction in spark frequency ( Figure 2D ). Wave amplitude did not change significantly in the presence of flecainide (see Supplementary material online, Figure S3B ).
Specific I Na blockade decreases spark and wave frequency
There are two broad mechanisms which may be responsible for the reduction in Ca 2+ waves in the presence of flecainide. First, by blocking Ca 2+ release from the RyR2, for which there is conflicting evidence in CPVT myocytes, 9,10 and second by inhibiting Na + influx with subsequent downstream effects. We aimed to assess the latter possibility-namely, whether SR Ca 2+ release can be altered by reducing Na + influx.
We therefore assessed the effect of specific pharmacological inhibition of I Na using 5 mM tetrodotoxin (TTX), a dose which was selected since it provides 25% I Na blockade in cardiomyocytes, 13 which is similar to that provided by 5 mM flecainide, 14 while still allowing Ca 2+ transients to occur with external field stimulation. Spark frequency was reduced ( Figure 3A ) from 3.76 + 0.48 to 2.24 + 0.52 sp/ mm/s in the presence of TTX (P ¼ 0.009). TTX also significantly reduced wave frequency ( Figure 3B ) and caused a reduction in wave velocity ( Figure 3C ) without changing wave amplitude (see Supplementary material online, Figure S3B ). Similar to results with flecainide, application of TTX at this concentration resulted in no significant alteration of SR load ( Figure 3D ). To assess whether this was a general property of other I Na blockers, further experiments to assess wave frequency under similar degrees of I Na blockade by 5 mM propafenone 15 and 200 mM lidocaine 16 were carried out. Both agents reduced waves in a similar manner to flecainide and TTX ( Figure 3E and F ). Together, these results strongly suggest that I Na is involved in wave formation.
How does I Na reduction decrease Ca 21 waves?
Two main possibilities could explain the involvement of I Na in wave formation. The first is that Na + entry via Na v 1.5 channels alters the sub-sarcolemmal 'fuzzy' space [Na + ] which subsequently modifies wave propagation via a number of possible downstream mechanisms (Mechanism A, Figure 4A ). The second is that Na v 1.5 channel activation is involved in the process of wave initiation and propagation more directly at the wave front (Mechanism B, Figure 4B ). If Mechanism A is accurate, then given its dependence on Na + influx via Na v 1.5, wave frequency should be reduced by an intervention which reduces Na + influx during the contraction train but leaves Na v 1.5 channels available during the quiescent period following the contraction train. Such a scenario was created using a voltage clamp technique to inactivate I Na during the stimulation train. Cells were stimulated by a 5 Hz train of clamp pulses (100 ms in duration) from 280 to 0 mV repeatedly for 1 min and waves assessed during a subsequent 30 s quiescent period when the cells were held at 280 mV.
The same cell was re-stimulated by another train of pulses from 240 to 0 mV, thereby removing Na + influx due to I Na inactivation. The final holding potential during the quiescent period was 280 mV as before to ensure availability of Na v 1.5 channels ( Figure 5A ). There was a significant reduction in wave frequency from 0.30 + 0.04 to 0.16 + 0.03 waves/s following inactivation of I Na by voltage clamp (
Figure 5B), suggesting greater importance of Mechanism A.
To confirm these findings and assess whether Mechanism B might also be playing a role, we designed an experiment which would allow normal Na + influx during the contraction train but would profoundly reduce availability of Na v 1.5 channels during the quiescent phase. A stimulation train was induced by external field stimulation for 30 s at 5 Hz and waves were assessed as before in the control condition (NT + vehicle). The same cell was then exposed to the same protocol but high-dose TTX (50 mM TTX, which blocks .95% of I Na 13 ) was superfused over cells rapidly after 30 s stimulation in NT to stop the Figure S5 ). This provided evidence of Na v 1.5 blockade during the quiescent period while ensuring the SR loading protocol was identical.
Results of these experiments showed that acute, profound Na v 1.5 blockade did not alter Ca 2+ wave frequency or velocity ( Figure 5C and D), suggesting that Mechanism B either does not occur or is of relatively minor importance compared with Mechanism A.
Mechanism of wave reduction with flecainide
Having shown that I Na reduction during the contraction train can reduce the frequency and velocity of Ca 2+ waves, we wished to assess whether this effect also played a role in the effects we had observed with flecainide. We first assessed whether, in the absence of I Na , flecainide would still reduce wave frequency-potentially through an additional effect on the RyR2. In order to test this possibility, we performed voltage clamp experiments. With a stimulation train of voltage clamp steps from 280 to 0 mV, as expected, there was a significant reduction in Ca 2+ waves ( Figure 5E ) in the presence of flecainide. However, when the stimulation train was induced by voltage steps from 240 to 0 mV (and so I Na was inactivated), there was no significant reduction in Ca 2+ wave frequency ( Figure 5F ) in the presence of flecainide. This provided evidence that reduced Na + influx was crucial in flecainide's mechanism of wave reduction.
To investigate how the changes in Na + influx into the cytosol altered wave frequency, we identified two possibilities that we felt were most likely to be the cause of the change. First, a reduction in used to assess wave frequency with and without I Na activity. Stimulation was induced by stepping from 280 to 0 mv (I Na active) or 240 to 0 mV (I Na inactive). Pulse duration was 100 ms and pulses were applied at 5 Hz. Waves were assessed in a subsequent 30 s interval during which membrane potential was held at 280 mV. (B) With I Na inactive during the stimulation train (but available during the quiescent phase of the experiment), wave frequency was reduced (P ¼ 0.002, n ¼ 7 cells). (C) High-dose (50 mM) TTX was rapidly applied to cells to terminate stimulation following a period of external field stimulation at 5 Hz and compared with the control arm in which stimulation was terminated in the usual fashion at 30 s (see Supplementary material online, Figure S4 for further explanation). This produced the opposite situation to the previous experiment with I Na active during the stimulation train but Na v 1.5 channels unavailable for stimulation during the quiescent phase. This produced no change in wave frequency (P ¼ 0.99, n ¼ 17 cells In order to investigate the former possibility, we used 1 mM KN-93 to inhibit CamKII prior to the addition of flecainide. In the presence of either KN-93 ( Figure 6A ) or KN-92 (see Supplementary material online, Figure  S5A ), flecainide remained able to reduce Ca 2+ wave frequency.
We subsequently assessed NCX function by observing the rate constant of Ca 2+ efflux following a caffeine transient in NT under the same conditions as waves were assessed (see Supplementary material online). There was a significant increase in Ca 2+ efflux via NCX following a contraction train in the presence of flecainide ( Figure 6B ). We subsequently assessed how such efflux would affect diastolic [Ca 2+ ] i in the period following the last fieldstimulated contraction and the first Ca 2+ wave, using the ratiometric dye fura-2. We found that there was a significant reduction in diastolic Ca 2+ by 12% (P ¼ 0.005, see Supplementary material online, Figure S5B ). In order to assess whether the opposite effect would occur with the inhibition of Ca 2+ efflux via NCX, we assessed the effects of partial NCX inhibition 18 with 1 mM NiCl 2 following the contraction train and found an increase in waves ( Figure 6C ). We sought to do this in the presence of flecainide to reverse the reduction in wave frequency. We found that a reduction of [Na + ] o after the contraction train from 140 to 125 mM was sufficient to reverse the wave reduction seen with flecainide ( Figure 6D and E). In order to ascertain whether the opposite effects would occur with I Na enhancement, we assessed whether 0.5 mM veratridine could increase Ca 2+ wave frequency. There was a significant increase in waves in the presence of veratridine which was reversed by increasing [Na] o from 115 to 140 mM.
Discussion

Main findings
The main finding of this study is that a reduction of I Na can reduce the frequency of Ca 2+ sparks and waves and the velocity of Ca 2+ waves.
This holds true whether I Na is pharmacologically reduced by a variety of agents or reduced by voltage clamp techniques. Initially, we wished to clarify whether this occurred via altering the intracellular ionic milieu (Mechanism A, Figure 4A ) or whether Na + influx was involved in the process of wave propagation itself (Mechanism B, Figure 4B ). A series of experiments inactivating I Na either during the stimulation train or the quiescent phase ( Figure 5 ) confirmed that a reduction in Na + influx is the most important mechanism involved in reducing Ca 2+ waves rather than implicating a role for Na v 1.5 channels at the Ca 2+ wave front. In further support of the importance of changes of cytosolic ionic milieu is the fact that very different I Na blockers including the neurotoxin TTX, class 1c drugs flecainide and propafenone, and the class 1b drug lidocaine produce a similar reduction in Ca 2+ wave frequency when concentrations producing similar degrees of I Na blockade are used. We used voltage clamp to assess whether a reduction in I Na was crucial for this effect. In the absence of I Na , flecainide is not able to reduce Ca 2+ waves, suggesting dominance of this mechanism over RyR2 blockade under our conditions. Figure 6B ). This resulted in a slight reduction in diastolic [Ca 2+ ] i in the quiescent period following our contraction train as assessed by fura-2 fluorescence (see Supplementary material online, Figure S5B ). In order to confirm the relevance of this mechanism, we modulated NCX function in other ways. Direct partial inhibition of NCX 18 with 1 mM Ni 2+ applied after the contraction train increased Ca 2+ waves ( Figure 6C ), suggesting that NCX is functioning predominantly in the inward mode under our experimental conditions. Impairing NCX increases waves by reducing Ca 2+ efflux. This helps to clarify how I Na blockade might Figure 6E) . Finally, we provide evidence that an increase in I Na can increase Ca 2+ wave frequency, using the Na v 1.5 channel activator veratridine ( Figure 6F) NCX has been largely neglected in the investigation of how I Na inhibitors can reduce SR Ca 2+ release. This is largely because, at high concentrations (e.g. 20 mM flecainide), some I Na inhibitors have direct effects on RyR2 in permeabilized cells and lipid bilayer experiments. 7 -9 It is not possible to compare our experiments directly with such previous work since ventricular myocytes from mouse models of CPVT were used. In these studies, contrasting results were presented, with Knollman and co-workers 7,9 reporting a reduction in wave frequency but increased spark frequency in both intact Casq2/2 and permeabilized normal rat ventricular myocytes and Liu et al. 10 finding no changes in sparks or waves with flecainide in either intact or permeabilized ventricular cardiomyocytes from RyR2 R4496C+/2 mice.
This inconsistency led us to investigate further despite the provision by Knollman and co-workers 7, 9 ' of multiple lines of evidence that RyR2 inhibition rather than altered Na + flux is the predominant mechanism of action in their experiments. In contrast, we find that without an active Na + current, no reduction in waves can be observed with flecainide. In addition, reduction in I Na alone, via various pharmacological agents and voltage clamp techniques, is sufficient to cause a reduction in wave frequency via enhancement of Ca 2+ efflux by NCX. Contributory to the differences between our work and other studies may be: (i) species difference and lack of CPVT model in our experiments; (ii) use of supra-therapeutic flecainide concentrations to obtain effects in permeabilized cells and lipid bilayer experiments by Knollman and co-workers while we used a therapeutically relevant concentration throughout; and (iii) lack of paired data in other studies which may reduce the power to detect differences in wave frequency (perhaps explaining the lack of efficacy seen with alternative I Na blockers such as TTX and lidocaine by Hwang et al. 24 ).
Limitations
Rapid application of caffeine is a well-accepted technique to assess SR load but may be insensitive to subtle changes in store Ca 2+ content.
We attempted to minimize inaccuracies by using a ratiometric dye and applying caffeine in the presence of Na + -free/Ca 2+ -free solution to obtain an accurate peak [Ca 2+ ] i .
Our voltage clamp trains from 280 to 0 mV vs. 240 to 0 mV, designed to eliminate I Na , could also alter NCX function during the contraction train; however, this would promote Ca 2+ entry at 240
vs. 280 mV and thus increase Ca 2+ waves rather than reduce them. Hence, this is not responsible for the reduction in wave frequency in the absence of I Na .
Conclusions
Reducing Na + influx during contraction in the intact cardiomyocyte reduces spontaneous diastolic SR Ca 2+ release both in the form of Ca 2+ sparks and waves. Given that SR load is unchanged, this is the result of reduced [Ca 2+ ] i in the vicinity of the RyR2 (due to enhanced efflux via NCX), which reduces the open probability of the channel. In the intact rat cardiomyocyte, this is the predominant mechanism of action for the reduction in Ca 2+ waves seen with flecainide at therapeutic concentrations. Other means of reducing Na + influx, such as I Na,L reduction, would be expected to reduce SR Ca 2+ leak via similar mechanisms.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
